Kenneth Gordon to Respiratory Tract Infections
This is a "connection" page, showing publications Kenneth Gordon has written about Respiratory Tract Infections.
Connection Strength
0.160
-
Risankizumab in moderate-to-severe plaque psoriasis. Immunotherapy. 2019 11; 11(16):1357-1370.
Score: 0.144
-
Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial. Arch Dermatol. 2008 Feb; 144(2):200-7.
Score: 0.016